BACKGROUND: We recently examined the methylation status of the HACE1 gene in primary carcinomas derived from 32 patients with colorectal cancer. A significant increase was observed in the maximal tumor size of the tumors with methylated HACE1 (p=0.0304). Moreover, a trend was shown toward preferentially developing lymph node metastasis in the carcinomas with methylated HACE1 (p=0.0612), suggesting that HACE1 might present a malignant potential in colorectal cancer. These results prompted us to examine the methylation status of the HACE1 gene in gastric carcinomas. MATERIALS AND METHODS: The methylation status of the HACE1 gene was examined in primary carcinomas and the corresponding normal tissues derived from 34 patients with gastric carcinoma using quantitative methylation-specific PCR (qMSP) and the correlation between the methylation status and the clinicopathological findings was evaluated. RESULTS: An aberrant methylation of the HACE1 gene was detected in 9 out of 34 (26%) primary gastric carcinomas. Subsequently, clinicopathological data were tested for correlation with the methylation score. A significant difference was observed in patient gender (p=0.0429). CONCLUSION: HACE1 was frequently methylated in gastric carcinoma derived from male patients.
BACKGROUND: We recently examined the methylation status of the HACE1 gene in primary carcinomas derived from 32 patients with colorectal cancer. A significant increase was observed in the maximal tumor size of the tumors with methylated HACE1 (p=0.0304). Moreover, a trend was shown toward preferentially developing lymph node metastasis in the carcinomas with methylated HACE1 (p=0.0612), suggesting that HACE1 might present a malignant potential in colorectal cancer. These results prompted us to examine the methylation status of the HACE1 gene in gastric carcinomas. MATERIALS AND METHODS: The methylation status of the HACE1 gene was examined in primary carcinomas and the corresponding normal tissues derived from 34 patients with gastric carcinoma using quantitative methylation-specific PCR (qMSP) and the correlation between the methylation status and the clinicopathological findings was evaluated. RESULTS: An aberrant methylation of the HACE1 gene was detected in 9 out of 34 (26%) primary gastric carcinomas. Subsequently, clinicopathological data were tested for correlation with the methylation score. A significant difference was observed in patient gender (p=0.0429). CONCLUSION:HACE1 was frequently methylated in gastric carcinoma derived from male patients.
Authors: Can Küçük; Xiaozhou Hu; Javeed Iqbal; Philippe Gaulard; David Klinkebiel; Adam Cornish; Bhavana J Dave; Wing C Chan Journal: Am J Pathol Date: 2012-11-09 Impact factor: 4.307
Authors: Melanie Kogler; Luigi Tortola; Gian Luca Negri; Alexandra Leopoldi; Amal M El-Naggar; Stefan Mereiter; Carlos Gomez-Diaz; Roberto Nitsch; Davide Tortora; Anoop M Kavirayani; Bianca V Gapp; Shuan Rao; Iris Uribesalgo; David Hoffmann; Domagoj Cikes; Maria Novatchkova; David A Williams; Jeffrey M Trent; Fumiyo Ikeda; Mads Daugaard; Astrid Hagelkruys; Poul H Sorensen; Josef M Penninger Journal: Cancer Res Date: 2020-05-04 Impact factor: 12.701
Authors: Sharon J Diskin; Mario Capasso; Robert W Schnepp; Kristina A Cole; Edward F Attiyeh; Cuiping Hou; Maura Diamond; Erica L Carpenter; Cynthia Winter; Hanna Lee; Jayanti Jagannathan; Valeria Latorre; Achille Iolascon; Hakon Hakonarson; Marcella Devoto; John M Maris Journal: Nat Genet Date: 2012-09-02 Impact factor: 38.330
Authors: N Cetinbas; M Daugaard; A R Mullen; S Hajee; B Rotblat; A Lopez; A Li; R J DeBerardinis; P H Sorensen Journal: Oncogene Date: 2014-10-06 Impact factor: 9.867